JP2015514679A5 - - Google Patents

Download PDF

Info

Publication number
JP2015514679A5
JP2015514679A5 JP2014551356A JP2014551356A JP2015514679A5 JP 2015514679 A5 JP2015514679 A5 JP 2015514679A5 JP 2014551356 A JP2014551356 A JP 2014551356A JP 2014551356 A JP2014551356 A JP 2014551356A JP 2015514679 A5 JP2015514679 A5 JP 2015514679A5
Authority
JP
Japan
Prior art keywords
pyridin
pyrrolo
dihydro
oxo
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014551356A
Other languages
English (en)
Japanese (ja)
Other versions
JP6175672B2 (ja
JP2015514679A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014551356A priority Critical patent/JP6175672B2/ja
Priority claimed from JP2014551356A external-priority patent/JP6175672B2/ja
Publication of JP2015514679A publication Critical patent/JP2015514679A/ja
Publication of JP2015514679A5 publication Critical patent/JP2015514679A5/ja
Application granted granted Critical
Publication of JP6175672B2 publication Critical patent/JP6175672B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014551356A 2012-04-25 2013-04-25 Ttx−s遮断薬としてのピロロピリジノン誘導体 Active JP6175672B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014551356A JP6175672B2 (ja) 2012-04-25 2013-04-25 Ttx−s遮断薬としてのピロロピリジノン誘導体

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261638085P 2012-04-25 2012-04-25
US61/638,085 2012-04-25
JP2012260231 2012-11-28
JP2012260231 2012-11-28
JP2014551356A JP6175672B2 (ja) 2012-04-25 2013-04-25 Ttx−s遮断薬としてのピロロピリジノン誘導体
PCT/JP2013/002825 WO2013161312A1 (en) 2012-04-25 2013-04-25 Pyrrolopyridinone derivatives as ttx-s blockers

Publications (3)

Publication Number Publication Date
JP2015514679A JP2015514679A (ja) 2015-05-21
JP2015514679A5 true JP2015514679A5 (cg-RX-API-DMAC10.html) 2017-06-22
JP6175672B2 JP6175672B2 (ja) 2017-08-09

Family

ID=49482654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014551356A Active JP6175672B2 (ja) 2012-04-25 2013-04-25 Ttx−s遮断薬としてのピロロピリジノン誘導体

Country Status (13)

Country Link
US (1) US9187475B2 (cg-RX-API-DMAC10.html)
EP (1) EP2841435B1 (cg-RX-API-DMAC10.html)
JP (1) JP6175672B2 (cg-RX-API-DMAC10.html)
KR (1) KR102090944B1 (cg-RX-API-DMAC10.html)
CN (1) CN104520296B (cg-RX-API-DMAC10.html)
BR (1) BR112014026283B1 (cg-RX-API-DMAC10.html)
CA (1) CA2871229C (cg-RX-API-DMAC10.html)
ES (1) ES2645984T3 (cg-RX-API-DMAC10.html)
IN (1) IN2014MN02056A (cg-RX-API-DMAC10.html)
MX (1) MX360323B (cg-RX-API-DMAC10.html)
RU (1) RU2646754C2 (cg-RX-API-DMAC10.html)
TW (1) TWI577677B (cg-RX-API-DMAC10.html)
WO (1) WO2013161312A1 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6173364B2 (ja) * 2014-01-29 2017-08-02 大正製薬株式会社 部分的に飽和された含窒素複素環化合物を有効成分として含有する医薬
MX383202B (es) * 2014-08-29 2025-03-13 Chdi Foundation Inc Sondas para la proyección de imagen de la proteína huntingtina.
US10202365B2 (en) 2015-02-06 2019-02-12 Blueprint Medicines Corporation 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
RS65069B1 (sr) 2015-11-02 2024-02-29 Blueprint Medicines Corp Inhibitori ret-a
WO2018112843A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
EP4230623A3 (en) * 2017-01-23 2023-10-11 Revolution Medicines, Inc. Pyridine compounds as allosteric shp2 inhibitors
MA49014A (fr) 2017-03-21 2020-02-05 Arbutus Biopharma Corp Dihydroindène-4-carboxamides substitués, leurs analogues et procédés d'utilisation correspondant
US11827616B2 (en) 2017-05-04 2023-11-28 Discovery Purchaser Corporation Heterocyclic compounds as pesticides
ES2970041T3 (es) 2018-04-03 2024-05-24 Blueprint Medicines Corp Inhibidor de RET para su uso en el tratamiento del cáncer que tiene una alteración de RET
CN113164461A (zh) * 2018-12-26 2021-07-23 拉夸里亚创药株式会社 作为Nav1.7及Nav1.8阻断剂的杂环衍生物
JP7413346B2 (ja) 2019-03-06 2024-01-15 第一三共株式会社 ピロロピラゾール誘導体
BR112022024382A2 (pt) 2020-05-29 2023-05-02 Blueprint Medicines Corp Formas sólidas de pralsetinibe
AU2024253757A1 (en) * 2023-04-07 2025-10-16 Biogen Ma Inc. 1h-pyrrolo[2,3-b]pyridin-4-yl]-2-oxopyrrolidine-3-carbonitrile derivatives as tyrosine kinase 2 (tyk2) inhibitors for the treatment of inflammatory diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002081446A1 (en) * 2001-04-06 2002-10-17 Daewoong Co., Ltd. 3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives and the use thereof
AU2003250482A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc Phthalimide derivatives as matrix metalloproteinase inhibitors
AR053713A1 (es) * 2005-04-20 2007-05-16 Xenon Pharmaceuticals Inc Compuestos heterociclicos y sus usos como agentes terapeuticos
NL2000284C2 (nl) 2005-11-04 2007-09-28 Pfizer Ltd Pyrazine-derivaten.
EP1984339A1 (en) * 2006-01-23 2008-10-29 Pfizer Limited Pyridine derivatives as sodium channel modulators
DE102006025318A1 (de) * 2006-05-31 2007-12-06 Bayer Healthcare Ag Dihydro-pyrrolopyridin-, Dihydro-pyrrolopyridazin- und Dihydro-pyrrolopyrimidin-Derivate und ihre Verwendung
CA2666136A1 (en) * 2006-10-12 2008-04-17 Xenon Pharmaceuticals Inc. Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents
RU2537549C2 (ru) * 2008-01-04 2015-01-10 Интелликайн ЭлЭлСи Некоторые химические структуры, композиции и способы
US20120040950A1 (en) * 2009-12-22 2012-02-16 Vertex Pharmaceuticals Incorporated Isoindolinone inhibitors of phosphatidylinositol 3-kinase
WO2011083316A1 (en) * 2010-01-08 2011-07-14 Takeda Pharmaceutical Company Limited Benzazepine derivatives for the treatment of central nervous system disorders
US8999974B2 (en) 2010-08-09 2015-04-07 Raqualia Pharma Inc. Acyl piperazine derivatives as TTX-S blockers
CN106478497B (zh) * 2010-10-18 2020-05-08 拉夸里亚创药株式会社 作为ttx-s阻滞剂的芳胺衍生物
EP2632461A4 (en) * 2010-10-29 2014-04-02 Merck Sharp & Dohme Isoindolinone PDE10 INHIBITORS
US9938269B2 (en) * 2011-06-30 2018-04-10 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A

Similar Documents

Publication Publication Date Title
JP2015514679A5 (cg-RX-API-DMAC10.html)
RU2014147243A (ru) Производные пирролопиридинона в качестве ttx-s блокаторов
RU2013114352A (ru) Азабензотиазолы, композиции и способы применения
JP2017512794A5 (cg-RX-API-DMAC10.html)
RU2014147191A (ru) Амидопроизводные как блокаторы ttx-s
HRP20212000T1 (hr) Aminotriazolopiridini kao inhibitori kinaze
JP2017511794A5 (cg-RX-API-DMAC10.html)
RU2015115400A (ru) Гетероароматические соединения и их применение в качестве допаминовых D1 лигантов
HRP20130106T1 (hr) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
JP2013500247A5 (cg-RX-API-DMAC10.html)
JP2014531449A5 (cg-RX-API-DMAC10.html)
CA2494091A1 (en) Substituted furo [2,3-b| pyridine derivatives
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
JP2016523911A5 (cg-RX-API-DMAC10.html)
RU2006145205A (ru) Терапевтические соединения: пиридин в качестве каркаса
HRP20161011T1 (hr) Aril dihidropiridinoni i piperidinoni kao inhibitori mgat2
RU2002134487A (ru) Бензофены как ингибиторы il-1бета и tnf-альфа
KR20140044865A (ko) Jak 억제제로서의 피리딘-2(1h)-온 유도체
JP2013530957A5 (cg-RX-API-DMAC10.html)
RU2019133530A (ru) ПРОИЗВОДНЫЕ АМИДА В КАЧЕСТВЕ БЛОКАТОРОВ Nav1.7 И Nav1.8
JP2017530185A5 (cg-RX-API-DMAC10.html)
JP2017512786A5 (cg-RX-API-DMAC10.html)
JP2021501179A5 (cg-RX-API-DMAC10.html)
CA2601508A1 (en) Cyclopropanecarboxamide derivatives